About Content group
Content group is a company based in Bologna (Italy) founded in 2020 was acquired by e Agostini in November 2024. Content group offers products and services including Contract Development and Manufacturing, Eye Care Products, and Nasal Spray. Content group operates in a competitive market with competitors including Selkirk Pharma, BAG Health Care, Baccinex, Swissfillon and COC Pharmaceuticals, among others.
- Headquarter Bologna, Italy
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name C.O.C. Farmaceutici Srl
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
e Agostini
(Nov 13, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Content group
Content group offers a comprehensive portfolio of products and services, including Contract Development and Manufacturing, Eye Care Products, and Nasal Spray.
Offers development and production of pharmaceuticals and devices.
Provides drops for eye care in various containers.
Delivers sterile, preservative-free nasal solutions.
People of Content group
Unlock access to complete
Funding Insights of Content group
Detailed funding history for Content group
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Content group
Content group has secured backing from 1 investor. Prominent investors backing the company include Gruppo De Agostini.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A family-owned holding company focused on long-term value creation.
|
Locked | Locked | Locked |
Investor details for Content group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Content group
Investment portfolio details for Content group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Content group
Detailed financials for Content group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Content Group Comparisons
Peer comparison for Content group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Content group
Content group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Selkirk Pharma, BAG Health Care, Baccinex, Swissfillon and COC Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract manufacturing of pharmaceuticals is provided by Selkirk Pharma.
|
|
| Locked | Locked | Locked |
Transfusion and transplant diagnostic products are developed and marketed.
|
|
| Locked | Locked | Locked |
CDMO specializing in fill and finishing of sterile lyophilized or liquid dosage forms
|
|
| Locked | Locked | Locked |
End-to-end fill and finish consulting and management services are provided.
|
|
| Locked | Locked | Locked |
Provides contract development and manufacturing for pharmaceuticals, medical devices, and cosmetics.
|
|
| Locked | Locked | Locked |
Fill and finishing services are provided in Argentina.
|
Detailed competitors of Content group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Content Group
Complete news archive for Content group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Content group
Content group was founded in 2020.
Content group is headquartered in Bologna, Italy. It is registered at Bologna, Emilia-romagna, Italy.
Content Group was established in 2020 in Bologna, Italy, as a contract development and manufacturing organization. Operations focus on filling services tailored to the pharmaceuticals, medical devices, and cosmetics sectors. These services support production needs across these industries, with activities centered in Italy to serve regional and international clients. The companys domain, contentgroup.it, facilitates online engagement.
Content group's top competitors include Selkirk Pharma, BAG Health Care and Baccinex.
Content group offers Contract Development and Manufacturing, Eye Care Products, and Nasal Spray.
Content group has 1 investor. Key investors include Gruppo De Agostini.